Spinal muscular atrophy affects all the body's muscles. For a long time, it was considered a disease caused solely by the ...
Spinal muscular atrophy affects all the body’s muscles. For a long time, it was considered a disease caused solely by the ...
From left: Myosana CEO Matthew Lumley, with co-founders Stanley Froehner and Nick Whitehead. (Myosana and UW Photos) The news: Myosana Therapeutics, a Seattle startup developing gene therapy ...
Partnership leverages AI-powered genome design to optimize AAV constructs, accelerate lead candidate selection, and improve drug substance manufacturability for rare and ultra-rare neuromuscular ...
News Medical on MSN
Study uncovers cerebellar involvement and social impairment
Building on these findings, researchers at Leipzig University's Carl Ludwig Institute of Physiology have now investigated whether additional regions of the nervous system are involved in the ...
TORONTO--(BUSINESS WIRE)--Satellos Bioscience Inc. (“Satellos” or the “Company”) (TSX: MSCL, OTCQB: MSCLF), a public biotech company developing new small molecule therapeutic approaches to improve the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback